Development and Application of Antimicrobials

Dear Colleagues,

In the realm of healthcare, the relentless pursuit of advancements has led to groundbreaking developments in the field of antimicrobials. These powerful agents, designed to combat microorganisms such as bacteria, viruses, and fungi, have become indispensable tools in the fight against infectious diseases. As the global community faces evolving health challenges, the ongoing development and application of antimicrobials play a central role in shaping the future of medicine.

One of the key areas of focus in antimicrobial development lies in addressing antibiotic resistance, a pressing concern that threatens to render once-effective treatments obsolete. Researchers are actively exploring innovative compounds and novel approaches to counteract this resistance, ensuring the continued efficacy of antimicrobials. From synthetic compounds to bioengineered solutions, the landscape of antimicrobial development is diverse and dynamic.

Moreover, the application of antimicrobials extends beyond traditional medicine. With the advent of nanotechnology, researchers are exploring nano-sized antimicrobial particles that exhibit enhanced efficacy and targeted delivery, minimizing collateral damage to healthy cells. This precision in treatment marks a significant stride towards personalized medicine and more effective healthcare interventions.

As we navigate a world marked by emerging infectious threats, the continuous development and application of antimicrobials stand as a beacon of hope. This progress not only fortifies our arsenal against existing diseases but also positions us to effectively combat unforeseen health challenges that may arise. In the relentless pursuit of a healthier future, the collaborative efforts of scientists, healthcare professionals, and technological innovators ensure that antimicrobials remain a cornerstone in the foundation of modern medicine.

Dr. Virginia Fuochi
Dr. Pio Maria Furneri
Dr. Adriana Garozzo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antiviral activity
• antimicrobial activity
• probiotics
• bacteriocins
• essential oils
• natural extracts
• drug delivery systems
• drug development